MOSAMEDIX BV has a total of 23 patent applications. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AXIS INC, MALLUCCI LIVIO and CENT SYDNEY AREA HEALTH SERV.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | Australia | 4 | |
#3 | Canada | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | New Zealand | 3 | |
#6 | United States | 2 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Reutelingsperger Christiaan Peter Maria | 19 |
#2 | Moonen Peter Jozef Jacobus | 15 |
#3 | Vermaire Ad | 9 |
#4 | Vermaire Adriaan Thomas | 6 |
#5 | Moonen Peter | 5 |
#6 | Reutelingsperger Chris | 2 |
#7 | Adriaan Thomas Vermaire | 1 |
#8 | Peter Jozef Jacobus Moonen | 1 |
#9 | Reutelingsperger Christiaan Pe | 1 |
#10 | Christiaan Peter Maria Reutelingsperger | 1 |
Publication | Filing date | Title |
---|---|---|
AU2010254681A1 | Method for enhancing phagocytosis of phosphatidylserine-exposing cells | |
AU2009286244A1 | Radiolabeled annexins | |
WO2009123454A1 | Compositions and method for reducing scar formation in wound healing | |
WO2007069895A1 | Annexin derivatives suitable for pretargeting in therapy and diagnosis | |
US2006009381A1 | Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |